SKI Market

A+| A| A-|

Indian Indices

Sensex

78,330.39 45.32
( 0.06%)

Global Indices

Nasdaq

53,071.47 150.40
(0.28%)

Dow Jones

7,557.54 53.30
(0.71%)

Hang Seng

68,399.59 -1,338.10
(-1.92%)

Nikkei 225

10,649.07 -29.96
(-0.28%)

Forex

USD-INR

95.19 -0.09
(-0.09%)

EUR-INR

108.86 0.10
(0.10%)

GBP-INR

127.02 0.03
(0.03%)

JPY-INR

0.59 0.00
(-0.02%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

629.4942217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

68.31

181867.21

EPS(TTM)

Face Value()

Div & Yield %

100.29

0.44

Back

Board of Master Components recommends final dividend

Jun 05,2026

Master Components announced that the Board of Directors of the Company at its meeting held on 5 June 2026, inter alia, have recommended the final dividend of Rs 0.75 per equity Share (i.e. 7.5%) , subject to the approval of the shareholders.

78,330.39 45.32 ( 0.06%)

53,071.47 150.40 (0.28%)

7,557.54 53.30 (0.71%)

68,399.59 -1,338.10 (-1.92%)

10,649.07 -29.96 (-0.28%)

95.19 -0.09 (-0.09%)

108.86 0.10 (0.10%)

127.02 0.03 (0.03%)

0.59 0.00 (-0.02%)